CTKB EBITDA Margin

Cytek Biosciences Inc · EBITDA Margin

CTKB logo

CTKB EBITDA Margin

Latest reported-13.14%
CTKB EBITDA Margin (-27.61% → -13.14%)
High-resolution chart · PNG

CTKB ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytek Biosciences Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-8.6316%
2.3896%
-2.2838%
5.7865%
6.9723%
16.5512%
-27.6143%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.